BAY-6672 |
Antagonist of PTGFR
Probe Summary
Selectivity
Potency
In Vivo
Control Compounds
Chemical Information
References
Vendors
Download
Probe Summary
| Targets | Biochemical/Biophysical Potency | Cellular Potency |
|---|---|---|
| PTGFR |
|
|
Antagonist
up to 500 nM
Selectivity
In Vitro Selectivity Assessment
Selectivity Assessment Description:
> 420-fold selectivity vs prostanoids EP1–EP4, IP, DP, CRTH2 based on binding assays (Panlabs)
Outs ...
In Cell Selectivity Assessment
Selectivity Assessment Description:
hTP-R cell-based assay at Panlabs shows 200 fold selectivity in Cell-Based assay.
Potency Cellular
In Vitro
PTGFR
Mode of Action: Antagonist
Structure-Activity-Relationship data available? No
DOI Reference: 10.1021/acs.jmedchem.0c00834
In Vivo Validations
Mouse, Rat, Dog
Dose: 3-30 mg/Kg
Route of delivery:
Oral
Plasma half life:
3.4 (M), 3.8 (R), 14 (D) h
DOI Reference: 10.1021/acs.jmedchem.0c00834
Negative Control Compounds
BAY-403
Chemical Information
| Molecular Formula | C26H27BrClN3O3 |
| SMILEs | Cc1c(N2CCCC2)nc2ccc(Br)cc2c1C(=O)NC[C@H](CCC(=O)O)c1ccccc1Cl |
| InChI | InChI=1S/C26H27BrClN3O3/c1-16-24(20-14-18(27)9-10-22(20)30-25(16)31-12-4-5-13-31)26(34)29-15-17(8-11-23(32)33)19-6-2-3-7-21(19)28/h2-3,6-7,9-10,14,17H,4-5,8,11-13,15H2,1H3,(H,29,34)(H,32,33)/t17-/m0/s1 |
| Molecular weight | 543.09 Da |
| AlogP | 0.0 |
| HBond acceptors | 6 |
| HBond donors | 2 |
| Atoms | 61 |
References
Publications
Vendors
Note: This is not an exhaustive list and does not indicate endorsement by the portal.